Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

15 treatments under study, led by Prostate Cancer Screening

Research Leaders

20 sponsors active, led by Nanostics

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 12 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (8)
Phase 3 (1)

Trial Status

Completed5
Recruiting3
Active Not Recruiting2
Enrolling By Invitation1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05608694Not ApplicableActive Not RecruitingPrimary

MRI Screening in Men at High Risk of Developing Prostate Cancer

NCT06626022Phase 3RecruitingPrimary

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

NCT06830265Not ApplicableRecruitingPrimary

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

NCT03957252Active Not Recruiting

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

NCT06678828Not ApplicableEnrolling By Invitation

Clinical Utility of ClarityDX Prostate

NCT06923657Not ApplicableRecruitingPrimary

PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy

NCT06838325Not ApplicableCompletedPrimary

The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities

NCT07206693Completed

Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation

NCT04601272Completed

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

NCT04063566Not ApplicableCompletedPrimary

ReIMAGINE Prostate Cancer Screening

NCT03633214Not ApplicableUnknownPrimary

Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening

NCT01516801Not ApplicableCompletedPrimary

A Pragmatic Trial of the Effect of a Mailed Patient Flyer About Prostate Specific Antigen (PSA) Testing Prior to an Annual Exam

Showing all 12 trials

Research Network

Common Treatments

  • Prostate Cancer Screening1
  • Prostatespecific Antigen Psa Test1
  • Mri1
  • Claritydx Prostate Blinded1
  • Decision Aid1

Active Sponsors

  • Nanostics2
  • Alberta Prostate Cancer Research Initiative, APCaRI1
  • Alberta Innovates Health Solutions1
  • NYU Langone Health1
  • Motorcycle Ride for Dad1

Top Investigators

Related Conditions

  • Prostate Cancer4
  • Prostate Cancer Screening Decision2
  • Prostate Specific Antigen Screening1
  • Performance Assessment Of Novel Test1
  • Colon Cancer Screening1

Activity Timeline